Featured
Publications Update # 99
Publications Update # 97
Publications Update # 96
Publications Update # 95
Bowel Surgery and Complications
Publication Update # 94
Publications Update # 88
Publications Update # 87
Publications Update # 86
Publications Update # 85
Publications Update # 84
Publications Update # 83
Publications Update # 82
GYOEDU Resident: Non-Epithelial Tumors of the Ovary
Publications Update # 81
Publications Update # 80
Publications Update # 79
Publications Update # 78
Publications Update # 77
Publications Update # 76
GYOEDU One-on-One Coaching and Mentorship
Board Prep
-
TDxd: ILD and Pneumonitis Management
-
Bowel Surgery and Complications
-
Relevant Board Review Material from Publications Updates 51-90
-
Relevant Board Review Material from Publications Updates 1 - 50
-
SHAPE Trial Update - MIS vs. Open Simple Hyst
Cervical Cancer
-
COMPASSION 16
-
InnovaTV 301/ENGOT-cx12/GOG-3057: Tisotumab Vedotin for Recurrent Cervical Cancer
-
Advanced/Recurrent/Metastatic Cervical Cancer
-
Tisotumab in Cervical Cancer: InnovaTV 204/ GOG-3023/ENGOT-cx6 Phase 2 trial
-
GOG 240: Bevacizumab in Advanced Cervical Cancer
Chemotherapy
Endometrial Cancer
-
Keynote B21 - Pembrolizumab in High-Risk Endometrial Cancer (Video Explainer)
-
ATtend Trial: Atezolizumab + chemotherapy for advanced or recurrent endometrial cancer
-
SIENDO Trial: Selinexor in TP53wt Advanced or Recurrent Endometrial Cancer
-
GOG 238: Radiation With or Without Cisplatin in Endometrial Cancer
-
ENGOT-EN5/GOG-3055/SIENDO: Selinexor in Endometrial Cancer (Phase II)
External Videos
Gynecology Oncology 101
-
Resident Assessment Quiz - Ovarian Cancer
-
GYOEDU Resident: Locally Advanced and Advanced/Metastatic Cervical Cancer
-
GYOEDU Resident: Early Cervical Cancer Management
-
GYOEDU Resident: Recurrent Endometrial Cancer
-
GYOEDU Resident: Uterine Sarcomas
GYOEDU Board Review Course
-
Bowel Surgery and Complications
-
Relevant Board Review Material from Publications Updates 51-90
-
Relevant Board Review Material from Publications Updates 1 - 50
-
SHAPE Trial Update - MIS vs. Open Simple Hyst
-
HER2 Testing and T-DXd
Leadership
-
Feedback Action Plan
-
Leadership Styles
-
GYOEDU One-on-One Coaching and Mentorship
-
Feedback
-
RHIP Framework for Change Management
Medical
Ovarian Cancer
-
Management of STIC in Patients Undergoing RRSO
-
Ovarian Borderline Tumors
-
GYOEDU Resident: Ovarian Cancer Part 3
-
HIPEC in ovarian cancer
-
Korean HIPEC trial
Palliative Care
podcast
Publications Update
-
Publications Update # 100
-
Publications Update # 99
-
Publications Update # 98
-
Publications Update # 97
-
Publications Update # 96
Questions
-
Pulmonary Embolism
-
Vulvar Melanoma Question
-
Metabolic Derangement in Ileal Conduits
-
Cellular Proliferation and Cell Cycle Questions
-
Chemotherapy Questions
Sarcoma
Study Summaries
-
NRG-GY023: Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab
-
ARIEL 4
-
PALETTE STUDY - Pazopanib for sarcoma
-
Fulvestrant + Abemaciclib
-
CHIPOR Trial: Secondary Debulking and HIPEC in Platinum Sensitive Recurrence
Surgical Videos
-
Gastrostomy Tube Placement
-
Ovarian Transposition
-
Reducing Incisional Hernias
-
Double-Barrelled Wet Colostomy
-
Finding ureters using ICG
Video Lectures
-
Antiangiogenesis and PD-1 Blockade
-
Bleomycin
-
PD-1 vs. PD-L1
-
The Rolling Thunder Fundamentals of Gynecologic Oncology
-
The GoodFellas
Vulvar Cancer
-
Vulvar Melanoma
-
Advanced Vulvar Carcinoma
-
Early Stage Vulvar Carcinoma
-
GROINS V II: Radiotherapy Versus Inguinofemoral Lymphadenectomy
-
GOG 279: Cisplatin, Gemcitabine, and IMRT for Locally Advanced Vulvar Carcinoma
Welcome
Worklife Balance
-
The Living Room
-
Free Solo
-
Mental Health Crisis in Surgeons
-
Trauma Stewardship
-
3 Practices for Wisdom and Wholeness